Support for IL-33 as a central mediator of human airway disease is derived from genome-wide association studies (4–6), and analysis of specimens from human asthma (7, 8) and patients with chronic obstructive pulmonary disease (COPD) (9–12). This evidence concerns the gene IL33 and chronic obstructive pulmonary disease.